Loan AgreementLoan Agreement • October 3rd, 2018 • Windtree Therapeutics Inc /De/ • Biological products, (no disgnostic substances) • New York
This Loan Agreement (this “Loan Agreement”), dated as of September 27, 2018, is entered into between Windtree Therapeutics, Inc., a Delaware corporation with its principal offices at 2600 Kelly Rd., Suite 100, Warrington, PA 18976 (“Borrower”), and LPH Investments Ltd., a Cayman Islands company organized and existing under the laws of Cayman Islands with its principal offices at 1/F, Building 20E, Phase 3, Hong Kong Science Park, Shatin, Hong Kong (“Lender”).
AMENDMENT NO. 3 TORestricted Stock Unit Award Agreement • October 3rd, 2018 • Windtree Therapeutics Inc /De/ • Biological products, (no disgnostic substances)
Effective as of September 30, 2018, John Tattory (“Participant”) and Windtree Therapeutics, Inc. (the “Company”) hereby agree to amend the Restricted Stock Unit (“RSU”) Award Agreement between them dated as of November 1, 2017 and the related notice of award (as it may have been previously amended, the “RSU Agreement”) to reflect the revisions set forth herein (“Amendment No. 3”). Capitalized terms used herein and not otherwise defined shall have the meanings ascribed to such terms in the RSU Agreement.
AMENDMENT NO. 3 TORestricted Stock Unit Award Agreement • October 3rd, 2018 • Windtree Therapeutics Inc /De/ • Biological products, (no disgnostic substances)
Effective as of September 30, 2018, Steven G. Simonson, M.D. (“Participant”) and Windtree Therapeutics, Inc. (the “Company”) hereby agree to amend the Restricted Stock Unit (“RSU”) Award Agreement between them dated as of November 1, 2017 and the related notice of award (as it may have been previously amended, the “RSU Agreement”) to reflect the revisions set forth herein (“Amendment No. 3”). Capitalized terms used herein and not otherwise defined shall have the meanings ascribed to such terms in the RSU Agreement.
AMENDMENT NO. 3 TORestricted Stock Unit Award Agreement • October 3rd, 2018 • Windtree Therapeutics Inc /De/ • Biological products, (no disgnostic substances)
Effective as of September 30, 2018, Craig Fraser (“Participant”) and Windtree Therapeutics, Inc. (the “Company”) hereby agree to amend the Restricted Stock Unit (“RSU”) Award Agreement between them dated as of November 1, 2017 and the related notice of award (as it may have been previously amended, the “RSU Agreement”) to reflect the revisions set forth herein (“Amendment No. 3”). Capitalized terms used herein and not otherwise defined shall have the meanings ascribed to such terms in the RSU Agreement.
